Archive summary

CNS Drug Developers Add Pharma Veterans as Sector Nears First FDA Decisions

Issued on behalf of Cybin D/B/A Helus PharmaUSANewsGroup.com News CommentaryVANCOUVER, BC, March 9, 2026 /CNW/ -- The central nervous system therapeutics sector is approaching a commercial inflection point as multiple candidates advance through late-stage trials and regulatory milestones accumulate1

Summary of reporting by benzinga March 10, 2026 1 min read Markdown